VMV. Yu. Matveev

V. Yu. Matveev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


V. Yu. Matveev has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A multidisciplinary approach in the treatment of thoracic endometriosis

    by R. I. Gabidullina, V. Yu. Matveev, F. F. Minnullina, A. I. Kuptsova, D. I. Akhmetova, I. M. Perevertov

    Purpose. To familiarize gynecologists with the clinical presentation, diagnosis and basic principles of treatment of thoracic endometriosis (TE).Materials and Methods. The article presents a review of publications based on the results of search in electronic resources PubMed, Elibrary, EMBASE. The own clinical observation of the patient with TE is also presented.Results. The clinical picture of TE can be different, in many patients it is asymptomatic. The typical symptom of TE is menstrual cycle-related, usually right-sided pain in the thoracic, scapular or shoulder area. Chest X-rays, computed tomography (CT), magnetic resonance imaging (MRI) and bronchoscopy are used in diagnosis. The gold standard for definitive diagnosis and effective treatment is video-assisted thoracoscopic surgery (VATS). As with pelvic disease, the first-line therapy for TE is medication to suppress ovarian steroid hormone production. Surgical treatment should be considered in patients with refractory or recurrent TE and in acute life-threatening conditions.Conclusion. Management of patients with thoracic endometriosis requires an interdisciplinary approach involving gynecologists and thoracic surgeons.

  • Open Access

    Experience in Using 99mTc-Technephyt Esophageal Transit Scintigraphy for Assessing Pneumatic Dilation Outcome in Patients with Achalasia Cardia

    by R. A. Bashirov, A. I. Shelepova, L. E. Samoilenko, S. A. Ryzhkin, B. M. Sharafutdinov, A. F. Yusupova, L. F. Ziganshina, B. A. Magomedov, A. I. Kukushkin, V. Yu. Matveev, et al.

    Objective: to show the possibility of using 99mTc-technephyt esophageal transit scintigraphy (ETS) to assess the effect of cardiodilation in patients with achalasia cardia.Material and methods. We examined 7 patients (6 males and 1 female) aged 44–73 years (mean age 57.8 years) diagnosed with achalasia cardia, who were treated in Department of Thoracic Surgery No. 2 at Republican Clinical Hospital from June 2022 to January 2023. The disease duration before admission to the hospital ranged from 2 to 17 years (mean 9.2 years).Results. The analysis of ETS results showed a decreased radiopharmaceutical residual activity percentage in cardia for all patients after treatment compared with the initial data. It indicated a positive effect of cardiodilation and coincided with X-ray examination data. The obtained results demonstrate the possibility of ETS using and its practical significance to assess the effect of therapeutic measures, in particular cardiodilation, in patients with achalasia cardia.Conclusion. Performed according to the described protocol, ETS is a physiological and safe method for both the diagnosis of achalasia and the subsequent assessing therapeutic effect, including cardiodilation, myotomy, conservative treatment, and long-term dynamic monitoring. It is a physiological and safe procedure, which can be recommended in cases of difficulties in evaluating the esophageal function by X-ray, endoscopic and manometric methods or when their use is impossibile.